Also listed on Avir Green Hills Biotechnology Research Development Trade AG, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends May 16, 2030 · High confidence
20-year base term ends Dec 22, 2028
Filed Aug 23, 2010 as application 12/809,814 · Granted Nov 26, 2013
Base term plus 510 days of patent term adjustment (USPTO delay)
Today
2008
2030
Clock starts
Dec 22, 2008
Dec 22, 2008
Term ends
May 16, 2030
May 16, 2030
Granted
Nov 26, 2013
Nov 26, 2013
base term
patent term adjustment
fee events
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
510
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 510 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 22, 2008, when application PCT/EP2008/068154, the earliest non-provisional in its chain, was filed (this one was filed Aug 23, 2010) | Dec 22, 2028 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +510 days, USPTO patent term adjustment record | May 16, 2030 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | May 16, 2030 | High confidence |
Partial family
| Application PCT/EP2008/068154 | PCT application no patent term | no patent term |
| US 8,592,196 | this patent May 2030 | May 2030 |
Partial: 1 of the 2 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 23, 2010 Reel 24869, frame 895 | Kittel, Christian; Wressnig, Nina | Avir Green Hills Biotechnology Research Development Trade AG | Assignment of Assignor's Interest |
| Mar 14, 2013 Reel 29996, frame 569 | Avir Green Hills Biotechnology Research Development Trade AG | Baxter Healthcare S.A. | Assignment of Assignor's Interest |
| Mar 18, 2013 Reel 30034, frame 893 | Avir Green Hills Biotechnology Research Development Trade AG | Baxter Healthcare S.A. | Assignment of Assignor's Interest |
| Aug 18, 2015 Reel 36388, frame 729 | Baxter Healthcare S.A. | Baxalta GmbH | Assignment of Assignor's Interest |
| Nov 24, 2015 Reel 37155, frame 732 | Baxalta GmbH | Nanotherapeutics, Inc. | Assignment of Assignor's Interest |
| May 2, 2016 Reel 38592, frame 44 | Baxalta GmbH | Nanotherapeutics, Inc. | Corrective Assignment to Correct the Correspondence Data Previously Recorded on Reel 037155 Frame 0732. Assignor(S) Hereby Confirms the Assignment. |
| May 1, 2018 Reel 46050, frame 305 | Ology Bioservices, Inc. | Midcap Financial Trust, As Agent | Security Interest |
| Jan 23, 2019 Reel 48117, frame 275 | Nanotherapeutics, Inc. | Ology Bioservices, Inc. | Change of Name |
| Aug 20, 2020 Reel 53561, frame 70 | Midcap Financial Trust, As Agent | Ology Bioservices, Inc.; Nano Adm, LLC | Release of Security Interest |
| Aug 20, 2020 reel/frame not recorded | Midcap Financial Trust, As Agent | Ology Bioservices, Inc. | Release of Security Interest |
| Aug 20, 2020 reel/frame not recorded | Midcap Financial Trust, As Agent | Nano Adm, LLC | Release of Security Interest |
| Sep 8, 2022 Reel 61399, frame 903 | Ology Bioservices, Inc. | Resilience Government Services, Inc. | Change of Name |
| Nov 20, 2025 Reel 73279, frame 21 | Resilience Government Services, Inc., | Alachua Government Services, Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
May 2030
Term ends May 16, 2030. No further fees fall due before then
Note
The 510 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
6
later US patents cite this one
That is below the median of utility patents granted in 2013 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.